In neuroblastoma, MKRN2 down‐regulated the expression of IGF2BP3‐targeted downstream pathways, indicating a negative regulatory effect of ubiquitination on IGF2BP3 function. The gene discussed is MKRN2; the disease is neuroblastoma.